EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

Successful Treatment with Imipenem/Cilastatin/Relebactam of a Polymicrobial Bacteremia due to Meropenem/Vaborbactam-Resistant KPC-Producing Klebsiella pneumoniae and Enterococcus faecalis

Federico Marzi, Mario Alessandri, Veronica De Crescenzo, Stefania Del Vecchio, Simone Radi, Maurizio Manini

Mediterranean Journal of Hematology and Infectious Diseases · 30.04.2026 · 18 (1) · e2026037

DOI: 10.4084/mjhid.2026.037 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Mediterranean Journal of Hematology and Infectious Diseases, online erschienen am 30.04.2026. Verfasst von Federico Marzi und 5 weiteren Autor:innen. Beteiligte Einrichtung: UOC Medicina Interna, Ospedale S. Giovanni di Dio, Orbetello, Usl Toscana Sud Est, Italy. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dear Editor, Carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) remains a major global health challenge, associated with high mortality and limited therapeutic options [1,2]. Although novel β-lactam/β-lactamase inhibitor combinations (BL/BLI), such as meropenem/vaborbactam (M/V), have improved treatment outcomes, M/V-resistance is increasingly reported, often due to porin alterations or overexpression of blaKPC genes [2,4,7]. Imipenem/cilastatin/relebactam (IMI/REL) represents an alternative strategy, combining a carbapenem with a potent class A/C β-lactamase inhibitor that can restore activity against certain carbapenemase-producing strains [3–6].Herein, we describe the first documented case of successful treatment of a polymicrobial bloodstream infection caused by M/V-resistant but IMI/REL-susceptible KPC-Kp, with concomitant Enterococcus faecalis, in an elderly, frail patient.

Schlagwörter

Stichwörter der Autor:innen

Imipenem/Cilastatin/RelebactamKPCMeropenemVaborbactam

Autor:innen und Institutionen

  • UOC Medicina Interna, Ospedale S. Giovanni di Dio, Orbetello, Usl Toscana Sud Est, Italy.

Zitieren

APA

Marzi, F., Alessandri, M., De Crescenzo, V., Del Vecchio, S., Radi, S., & Manini, M. (2026). Successful Treatment with Imipenem/Cilastatin/Relebactam of a Polymicrobial Bacteremia due to Meropenem/Vaborbactam-Resistant KPC-Producing Klebsiella pneumoniae and Enterococcus faecalis. Mediterranean Journal of Hematology and Infectious Diseases, 18(1), e2026037. https://doi.org/10.4084/mjhid.2026.037

Vancouver

Marzi F, Alessandri M, De Crescenzo V, Del Vecchio S, Radi S, Manini M. Successful Treatment with Imipenem/Cilastatin/Relebactam of a Polymicrobial Bacteremia due to Meropenem/Vaborbactam-Resistant KPC-Producing Klebsiella pneumoniae and Enterococcus faecalis. Mediterranean Journal of Hematology and Infectious Diseases. 2026;18(1):e2026037. doi:10.4084/mjhid.2026.037

BibTeX
@article{Marzi2026,
  author = {Marzi, Federico and Alessandri, Mario and De Crescenzo, Veronica and Del Vecchio, Stefania and Radi, Simone and Manini, Maurizio},
  title = {Successful Treatment with Imipenem/Cilastatin/Relebactam of a Polymicrobial Bacteremia due to Meropenem/Vaborbactam-Resistant KPC-Producing Klebsiella pneumoniae and Enterococcus faecalis},
  journal = {Mediterranean Journal of Hematology and Infectious Diseases},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {e2026037},
  doi = {10.4084/mjhid.2026.037}
}
Kostenlos starten →